Reflections of the Anti-inflammatory Properties of Aspirin on Cardiovascular Disease and Diabetes Mellitus-related Pathological Markers

Abstract

Hind Makki Abdlwahid, Majid Mohammed Mahmood, Asaad F. Albayati.

To keep track of immune modulating effects of using prophylactic acetylsalicylic acid (ASA) or aspirin in Iraqi community, 60 selected patients taking aspirin were divided into two groups, depending on their medical conditions, group I (30 patient having cardiovascular disease), group II (30 patient having diabetes mellitus), versus 20 matched corresponding patients, don’t take aspirin, who were depended as control groups (ten each). All were tested for their inflammatory markers including levels of interleukin-1β (IL-1β), interleukin 6 (IL6) and high sensitivity C-reactive protein (hsCRP) by using ELIZA technique. Results recorded decreased levels of IL1β (0.357±0.03pg/ml), and IL6 (2.22 ±0.26pg/ml) in group I and (0.250 ± 0.02pg/ml) (1.450 ± 0.22pg/ml) in group II, compared to their counterparts of controls (5.31±1.29pg/ml) (12.66±1.46pg/ml), and (5.58±1.29pg/ml) (7.63±0.75pg/ml) in succession. Such results indicate the beneficial immune regulatory action of aspirin in cardiovascular and diabetic patients. Rather hsCRP showed no significant variations in both groups of patients compared to their controls; (4.039±0.29ng/ml vs 3.290±0.65ng/ml) and (5.06 ± 0.40ng/ml vs 6.29±0.54 ng/ml), respectively.

How to Cite this Article
Pubmed Style

Abdlwahid HM, Mahmood MM, Albayati AF. Reflections of the Anti-inflammatory Properties of Aspirin on Cardiovascular Disease and Diabetes Mellitus-related Pathological Markers. SRP. 2020; 11(7): 393-395.
doi:10.31838/srp.2020.7.58

Web Style

Abdlwahid HM, Mahmood MM, Albayati AF. Reflections of the Anti-inflammatory Properties of Aspirin on Cardiovascular Disease and Diabetes Mellitus-related Pathological Markers. http://www.sysrevpharm.org/?mno=127985 [Access: March 28, 2021]. doi:10.31838/srp.2020.7.58

AMA (American Medical Association) Style

Abdlwahid HM, Mahmood MM, Albayati AF. Reflections of the Anti-inflammatory Properties of Aspirin on Cardiovascular Disease and Diabetes Mellitus-related Pathological Markers. SRP. 2020; 11(7): 393-395. doi:10.31838/srp.2020.7.58



Vancouver/ICMJE Style

Abdlwahid HM, Mahmood MM, Albayati AF. Reflections of the Anti-inflammatory Properties of Aspirin on Cardiovascular Disease and Diabetes Mellitus-related Pathological Markers. SRP. (2020), [cited March 28, 2021]; 11(7): 393-395. doi:10.31838/srp.2020.7.58



Harvard Style

Abdlwahid, H. M., Mahmood, . M. M. & Albayati, . A. F. (2020) Reflections of the Anti-inflammatory Properties of Aspirin on Cardiovascular Disease and Diabetes Mellitus-related Pathological Markers. SRP, 11 (7), 393-395. doi:10.31838/srp.2020.7.58



Turabian Style

Abdlwahid, Hind Makki, Majid Mohammed Mahmood, and Asaad F. Albayati. 2020. Reflections of the Anti-inflammatory Properties of Aspirin on Cardiovascular Disease and Diabetes Mellitus-related Pathological Markers. Systematic Reviews in Pharmacy, 11 (7), 393-395. doi:10.31838/srp.2020.7.58



Chicago Style

Abdlwahid, Hind Makki, Majid Mohammed Mahmood, and Asaad F. Albayati. "Reflections of the Anti-inflammatory Properties of Aspirin on Cardiovascular Disease and Diabetes Mellitus-related Pathological Markers." Systematic Reviews in Pharmacy 11 (2020), 393-395. doi:10.31838/srp.2020.7.58



MLA (The Modern Language Association) Style

Abdlwahid, Hind Makki, Majid Mohammed Mahmood, and Asaad F. Albayati. "Reflections of the Anti-inflammatory Properties of Aspirin on Cardiovascular Disease and Diabetes Mellitus-related Pathological Markers." Systematic Reviews in Pharmacy 11.7 (2020), 393-395. Print. doi:10.31838/srp.2020.7.58



APA (American Psychological Association) Style

Abdlwahid, H. M., Mahmood, . M. M. & Albayati, . A. F. (2020) Reflections of the Anti-inflammatory Properties of Aspirin on Cardiovascular Disease and Diabetes Mellitus-related Pathological Markers. Systematic Reviews in Pharmacy, 11 (7), 393-395. doi:10.31838/srp.2020.7.58

 

Most Viewed Articles
  • Dental Development between Assisted Reproductive Therapy (Art) and Natural Conceived Children: A Comparative Pilot Study Norzaiti Mohd Kenali, Naimah Hasanah Mohd Fathil, Norbasyirah Bohari, Ahmad Faisal Ismail, Roszaman Ramli SRP. 2020; 11(1): 01-06 » doi: 10.5530/srp.2020.1.01
  • Psychometric properties of the World Health Organization Quality of life instrument, short form: Validity in the Vietnamese healthcare context Trung Quang Vo*, Bao Tran Thuy Tran, Ngan Thuy Nguyen, Tram ThiHuyen Nguyen, Thuy Phan Chung Tran SRP. 2020; 11(1): 14-22 » doi: 10.5530/srp.2019.1.3
  • A Review of Pharmacoeconomics: the key to “Healthcare for All” Hasamnis AA, Patil SS, Shaik Imam, Narendiran K SRP. 2019; 10(1): s40-s42 » doi: 10.5530/srp.2019.1s.21
  • Deuterium Depleted Water as an Adjuvant in Treatment of Cancer Anton Syroeshkin, Olga Levitskaya, Elena Uspenskaya, Tatiana Pleteneva, Daria Romaykina, Daria Ermakova SRP. 2019; 10(1): 112-117 » doi: 10.5530/srp.2019.1.19
Most Downloaded
  • Dental Development between Assisted Reproductive Therapy (Art) and Natural Conceived Children: A Comparative Pilot Study Norzaiti Mohd Kenali, Naimah Hasanah Mohd Fathil, Norbasyirah Bohari, Ahmad Faisal Ismail, Roszaman Ramli SRP. 2020; 11(1): 01-06 » doi: 10.5530/srp.2020.1.01
  • Manilkara zapota (L.) Royen Fruit Peel: A Phytochemical and Pharmacological Review Karle Pravin P, Dhawale Shashikant C SRP. 2019; 10(1): 11-14 » doi: 0.5530/srp.2019.1.2
  • Pharmacognostic and Phytopharmacological Overview on Bombax ceiba Pankaj Haribhau Chaudhary, Mukund Ganeshrao Tawar SRP. 2019; 10(1): 20-25 » doi: 10.5530/srp.2019.1.4
  • A Review of Pharmacoeconomics: the key to “Healthcare for All” Hasamnis AA, Patil SS, Shaik Imam, Narendiran K SRP. 2019; 10(1): s40-s42 » doi: 10.5530/srp.2019.1s.21
  • A Prospective Review on Phyto-Pharmacological Aspects of Andrographis paniculata Govindraj Akilandeswari, Arumugam Vijaya Anand, Palanisamy Sampathkumar, Puthamohan Vinayaga Moorthi, Basavaraju Preethi SRP. 2019; 10(1): 15-19 » doi: 10.5530/srp.2019.1.3